Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTX-011 for Postoperative Pain After Inguinal Herniorrhaphy
NCT03237481Phase 3Completed
- Sponsor
- Heron Therapeutics, Inc.
- Start
- Jul 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of bupivacaine + meloxicam in postoperative pain, sponsored by Heron Therapeutics, Inc.. Started Jul 2017; status: completed.
02
Drugs
bupivacaine + meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03237481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03237481.